X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
CIPLA LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

CIPLA LIMITED   (CIPL)


Here is the latest financial fact sheet of Cipla. For more details, see the Cipla quarterly results and Cipla share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
CIPLA - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 556.1       No. of shares m 804.21
    Mkt Cap Rs m 447,221       % ch % -1.3
    Vol '000 690.8       % ch week % -3.5
    P/E X 38.1       % ch 1-mth % -6.3
    P/CF X 21.2       % ch 12-mth % 5.7
    EPS (TTM) Rs 14.6       52 week H/L Rs 621.9/458.3
(As on Apr 24, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs359435450753748 
Low Rs274301364369495 
Sales per share (Unadj.) Rs87.4103.1126.7141.3170.3 
Earnings per share (Unadj.) Rs14.319.217.314.718.7 
Diluted earnings per shareRs14.219.217.314.718.7 
Cash flow per share (Unadj.) Rs18.123.421.921.025.5 
Dividends per share (Unadj.) Rs2.002.002.002.002.00 
Adj. dividends per shareRs2.002.002.002.002.00 
Dividend yield (eoy) %0.60.50.50.40.3 
Book value per share (Unadj.) Rs95.1112.3125.2134.5147.6 
Adj. book value per shareRs95.0112.1125.0134.3147.4 
Shares outstanding (eoy) m802.92802.92802.92802.96803.38 
Bonus/Rights/Conversions  ---ESOPESOP 
Price / Sales ratio x3.63.63.24.03.7 
Avg P/E ratio x22.219.123.538.133.2 
P/CF ratio (eoy) x17.415.818.626.724.4 
Price / Book Value ratio x3.33.33.34.24.2 
Dividend payout %14.010.411.613.610.7 
Avg Mkt Cap Rs m254,124295,475326,829450,139499,381 
No. of employees `000NANANANA24.1 
Total wages/salary Rs m7,72510,36015,43019,73724,471 
Avg. sales/employee Rs ThNMNMNMNM5,677.3 
Avg. wages/employee Rs ThNMNMNMNM1,015.7 
Avg. net profit/employee Rs ThNMNMNMNM625.0 
  INCOME DATA
Net Sales Rs m70,20782,793101,734113,454136,783 
Other income Rs m1,3952,2212,6541,6562,089 
Total revenues Rs m71,60285,015104,388115,110138,872 
Gross profit Rs m16,61821,97921,33121,61725,011 
Depreciation Rs m3,1223,3053,7265,0475,417 
Interest Rs m3833391,4571,6831,613 
Profit before tax Rs m14,50820,55618,80016,54320,070 
Minority Interest Rs m00-159-482-494 
Prior Period Items Rs m0-62-123-253-120 
Extraordinary Inc (Exp) Rs m0398000 
Tax Rs m3,0655,4434,6344,0004,396 
Profit after tax Rs m11,44215,44913,88411,80815,059 
Gross profit margin %23.726.521.019.118.3 
Effective tax rate %21.126.524.624.221.9 
Net profit margin %16.318.713.610.411.0 
  BALANCE SHEET DATA
Current assets Rs m50,56867,84056,51475,91488,422 
Current liabilities Rs m14,13222,77625,63638,93679,089 
Net working cap to sales %51.954.430.432.66.8 
Current ratio x3.63.02.21.91.1 
Inventory Days Days96105104122102 
Debtors Days Days8174596463 
Net fixed assets Rs m35,86739,87844,45248,521110,786 
Share capital Rs m1,6061,6061,6061,6061,607 
"Free" reserves Rs m74,24887,81898,591105,484115,989 
Net worth Rs m76,38990,187100,504108,015118,574 
Long term debt Rs m3363,1793,0932,219 
Total assets Rs m93,498116,588134,032157,175208,926 
Interest coverage x38.861.613.910.813.4 
Debt to equity ratio x00000 
Sales to assets ratio x0.80.70.80.70.7 
Return on assets %12.613.511.48.68.0 
Return on equity %15.017.113.810.912.7 
Return on capital %19.523.519.315.717.4 
Exports to sales %52.653.548.641.748.9 
Imports to sales %16.115.914.014.712.6 
Exports (fob) Rs m36,92044,26249,48047,36366,837 
Imports (cif) Rs m11,33313,16214,26116,62917,270 
Fx inflow Rs m37,28244,94751,49949,10467,461 
Fx outflow Rs m13,29215,90618,94322,48324,729 
Net fx Rs m23,99029,04232,55626,62142,733 
  CASH FLOW
From Operations Rs m 17,128 13,977 15,633 11,734 17,939 
From Investments Rs m -9,651 -20,629 -12,499 -9,412 -45,795 
From Financial Activity Rs m -7,532 7,178 -2,656 1,648 31,027 
Net Cashflow Rs m -55 526 478 3,971 3,171 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for cipla limited

 Share Holding
Indian Promoters : 16.0%
Foreign collaborators : 20.8%
Indian inst/Mut Fund : 12.2%
FIIs : 23.7%
ADR/GDR : 1.1%
Free float : 26.2%
Shareholders : 161,166
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-13
    E-MAIL: cosecretary@cipla.com     WEB: www.cipla.com
    TELEPHONE: (022) 2482 6000     FAX: (022) 2482 6893
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
    AUDITOR: V. Sankar Aiyar & Co.
CHM: Y. K. Hamied (MD) COMP SEC: Mital Sanghvi YEAR OF INC: 1935 BSE CODE: 500087 FV (Rs): 2 DIV YIELD (%): 0.4

More pharmaceuticals Company Fact Sheets:   AJANTA PHARMAUNICHEM LABPIRAMAL ENTERPRISESAMAR REMEDIESTTK HEALTHCARE


Today's Market

Strong Start to the Week; Cement Stocks Rally(Closing)

Share markets in India finished on a strong footing tracking positive trend in global markets after the market's favored candidate, Emmanuel Macron, won the first round of the French presidential election.

Views on news

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Cipla: Weak Quarter, Positive Triggers Ahead (Quarterly Results Update - Detailed)

Sep 19, 2016

Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Cipla: Impacted by one offs (Quarterly Results Update - Detailed)

Jun 2, 2016

Cipla has announced its 4QFY16 results. The company has reported 7.6% YoY growth in sales and a decline of 68.9% YoY in net profits. Here is our analysis of the results.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

More Views on News

Most Popular

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

Aur Bhi Dukh Hain Zamane Main Stock Market Ke Siva...(Vivek Kaul's Diary)

Apr 13, 2017

The link between the Indian economy and the stock market is weak, and the stock market is not a reflection of the Indian economy.

The Real Reason Indiabulls Real Estate Jumped 42%(Daily Profit Hunter)

Apr 19, 2017

An elephant and six blind men will tell you more about the markets than any financial newspaper or channel.

7 Benefits Of Creating A CAN(Outside View)

Apr 13, 2017

The MFU platform offers ease, convenience, and speed of transacting in various mutual fund schemes.

More

TRACK CIPLA

MORE ON CIPLA

CIPLA - ALEMBIC PHARMA COMPARISON

Compare Company With Charts

COMPARE CIPLA WITH

MARKET STATS